NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

345 hedge funds and large institutions have $10.9B invested in Neurocrine Biosciences in 2018 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 94 increasing their positions, 115 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
345
Holders Change
+71
Holders Change %
+25.91%
% of All Funds
7.9%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
90
Increased
94
Reduced
115
Closed
17
Calls
$60.8M
Puts
$84.1M
Net Calls
-$23.2M
Net Calls Change
-$27M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$44.1M
2
1832 Asset Management
2
1832 Asset Management
Ontario, Canada
$79.2M
3
PC
3
Polar Capital
United Kingdom
$32.6M
4
Capital International Investors
4
Capital International Investors
California
$31.7M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$67.1M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$136M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$7.99M
3
TCM
3
TimesSquare Capital Management
New York
$118M
4
American Century Companies
4
American Century Companies
Missouri
$0
5
HM
5
HealthCor Management
New York
$50.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
CEP
126
Chicago Equity Partners
Illinois
$4.08M +$3.06M +24,875 +301%
ACI
127
Alpha Cubed Investments
California
$4.03M – – –
NA
128
Navellier & Associates
Nevada
$3.86M +$3.86M +31,394 New
BAMCO Inc
129
BAMCO Inc
New York
$3.82M +$164K +1,334 +4%
PA
130
Profund Advisors
Maryland
$3.8M +$371K +3,018 +11%
ECM
131
Element Capital Management
New York
$3.77M +$2.93M +23,836 +351%
BA
132
Boston Advisors
Massachusetts
$3.76M -$12.4M -100,873 -77%
AG
133
Aperio Group
California
$3.76M +$229K +1,866 +7%
SEC
134
Seven Eight Capital
New York
$3.57M +$3.57M +29,000 New
Verition Fund Management
135
Verition Fund Management
Connecticut
$3.54M +$3.54M +28,801 New
Citigroup
136
Citigroup
New York
$3.48M -$1.1M -8,985 -24%
Fisher Asset Management
137
Fisher Asset Management
Washington
$3.46M -$393K -3,195 -10%
IBT
138
International Biotechnology Trust
United Kingdom
$3.35M -$12.1M -128,000 -78%
Prudential Financial
139
Prudential Financial
New Jersey
$3.25M +$2.69M +21,890 +479%
Adage Capital Partners
140
Adage Capital Partners
Massachusetts
$3.2M -$15.5M -126,000 -83%
B
141
Barings
North Carolina
$3.1M +$3.1M +25,190 New
PP
142
Paloma Partners
Connecticut
$2.99M +$2.99M +24,345 New
Barclays
143
Barclays
United Kingdom
$2.97M +$216K +1,758 +8%
GAM
144
Gotham Asset Management
New York
$2.9M +$1.99M +16,209 +219%
Jane Street
145
Jane Street
New York
$2.89M +$2.55M +20,763 +750%
JPMPWA
146
J.P. Morgan Private Wealth Advisors
California
$2.89M -$23.1K -188 -0.8%
EU
147
Emory University
Georgia
$2.89M -$656K -5,334 -19%
Tudor Investment Corp
148
Tudor Investment Corp
Connecticut
$2.85M +$2.85M +23,158 New
ACM
149
Asymmetry Capital Management
California
$2.84M -$464K -3,777 -14%
SGAM
150
Steinberg Global Asset Management
Florida
$2.83M +$1.3M +10,538 +85%
4 5
6
7 8